';
Authors Posts by Jason Snyder

Jason Snyder

282 POSTS 0 COMMENTS

Concept of important day, reminder, organizing time and schedule - red pen marking day of the month on a calendar

Organizations wanting to include their recovery month events on the Department of Drug and Alcohol Programs’ National Recovery Month web page should email the DDAP Press Office.

September is National Recovery Month, which celebrates the gains made by those in recovery from substance use and mental health. Recovery Month works to promote and support new evidence-based treatment and recovery practices, the emergence of a strong and proud recovery community, and the dedication of service providers and community members across the nation who make recovery in all its forms possible.

Image by Gerd Altmann from Pixabay

RCPA is pleased to announce that Gaudenzia CEO Dale Klatzker has been appointed to the Behavioral Health Commission for Adult Mental Health.

The commission was created in the recently passed fiscal code as part of Pennsylvania’s fiscal year 2022/23 budget. Language in the law specifically directed the commission to include as a member, among others, “A recognized subject matter expert in the treatment of co-occurring mental health and substance use disorders from a list of recommendations compiled by the Rehabilitation and Community Providers Association with experience in behavioral health matters.” Gov. Wolf selected Klatzker from among a list of RCPA member behavioral health experts provided by the association.

A leader in behavioral health care for more than 35 years, Klatzker was appointed CEO of Gaudenzia, Inc. in March 2019. Gaudenzia operates substance use disorder (SUD) and co-occurring mental health (MH) programs in Pennsylvania, Maryland, Delaware, and Washington, D.C. Established in Philadelphia in 1968, Gaudenzia, Inc. is Pennsylvania’s largest non-profit provider of treatment for SUD and co-occurring disorders.

Before joining Gaudenzia, Klatzker held roles as senior consultant and chief clinical officer for The Margolin Group, as well as senior vice president, Population Health Management, for Care New England. Previous to those roles, he was president and CEO of The Providence Center (TPC) and was at the forefront of establishing programs that integrate primary and behavioral health care through community partnerships and strategic consumer-focused programming. Through his leadership, TPC became a national model for integrated care in community mental health settings.

Klatzker has been both locally and nationally recognized for his leadership and innovative contributions to the field. He has served as board chair of the National Council for Community Behavioral Healthcare, chair of Mental Health Corporations of America, fellow for the Rhode Island Foundation Fellows Program, associate clinical professor at Alpert Medical School at Brown University, adjunct professor of psychology at Johnson and Wales University, and adjunct assistant professor at the Department of Social Sciences and Education at Colby-Sawyer College. He also served on the Rhode Island Healthcare Reform Commission, Community Healthcare Providers Leadership Council, and numerous other commissions and committees.  He received his PhD from the Brandeis University Heller School and his MSW from Boston University.

Reporting to the Department of Human Services, the commission is to be comprised of 24 individuals from various state agencies or areas of specialty, as well as legislative appointees. The commission is charged with issuing a report of recommended funding allocations to the following areas. This funding will come from $100 million of federal American Rescue Plan funds.

  • Delivery of services by telemedicine;
  • Behavioral health rates, network adequacy, and mental health payment parity;
  • Workforce development and retention;
  • Expansion of certified peer support specialist services and peer-run services;
  • Development and provision of crisis services;
  • Integration of behavioral health and substance use disorder treatment;
  • Cultural competencies when providing behavioral health care;
  • Impact of social determinants of health on behavioral health;
  • Intersection of behavioral health and the criminal justice system; and
  • Integrating care that can deliver timely psychiatric care in a primary care setting.

On Tuesday, August 2, RCPA member Pyramid Healthcare joined the Department of Drug and Alcohol Programs (DDAP) to encourage use of the free and confidential Addiction Treatment Locator, Assessment, and Standards (ATLAS) platform in Pennsylvania.

ATLAS evaluates addiction treatment facilities’ use of evidence-based best practices based on the Shatterproof National Principles of Care, includes an assessment to understand the appropriate level of care, and offers an easy-to-use dashboard to allow those in need and their loved ones to search for and compare facilities using criteria such as location, services offered, and insurance accepted so they can find the best treatment for their unique needs. ATLAS is fully available in English and Spanish.

Founded in 1999 with headquarters in Altoona, Pyramid Healthcare is recognized as one of the largest, full-continuum providers of substance use treatment for adults and adolescents with 31 program locations in the commonwealth and 85 across seven eastern states.

“As a participating provider, Pyramid Healthcare proudly joins DDAP in support and promotion of ATLAS as an invaluable resource designed to bridge the gap between treatment access and client engagement within the commonwealth by helping individuals navigate available behavioral health treatment options that best fit their unique recovery needs,” said Jonathan Wolf, CEO of Pyramid Healthcare.

A multimedia package from the event is available online.

The Wolf Administration on Thursday announced the expansion of Acting Secretary of Health and Pennsylvania Physician General Dr. Denise Johnson’s naloxone standing order to now include ZIMHI, a 5 milligram (mg) intra-muscular injection device that comes as a single-dose pre-filled syringe or a carton containing two cases of pre-filled syringes. Residents can present a copy of the standing order at their local pharmacy to obtain life-saving naloxone.

Read the full press release.

On July 7, 2022, Gov. Wolf signed Act 33 of 2022, which amends Act 63 of 1972 as it pertains to confidentiality of substance use disorder patient records. Act 33 incorporates federal confidential protections under the Health Insurance Portability and Accountability Act (HIPAA) and 42 CFR Part 2. Act 33, which took effect immediately, prohibits the Pennsylvania Department of Drug and Alcohol Programs (DDAP) from promulgating or enforcing a regulation that restricts any disclosure of records or information that is permitted by Act 33. DDAP is currently reviewing Act 33 to determine next steps as a regulatory agency and will be providing additional information and details on the DDAP website in the near future.